A Philadelphia jury hit Janssen Pharmaceuticals with a $70 million verdict in a case over the antipsychotic drug Risperdal. The case, which was the fifth to go to trial from Philadelphia’s Risperdal-related mass tort program, resulted in the largest award out of that program by a factor of nearly 30.
The unanimous verdict in A.Y. v. Janssen Pharmaceuticals came down July 1 after two weeks of trial before Philadelphia Court of Common Pleas Judge Paula Patrick. The largest Risperdal-related award to come down in Philadelphia had previously been a $2.5 million award that a jury handed up in February 2015.
